
Opinion|Videos|May 29, 2024
Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
Diana Brixner, PhD, highlights the potential for prescription digital therapeutics (PDTs) to have impact in areas such as facilitating behavioral change for mental health conditions and strengthening adherence for complex disease states with intricate drug regimens.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar
2
HERIZON-GEA-01 Results Indicate Potential 1L Use of Zanidatamab for Gastroesophageal Adenocarcinoma
3
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
4
β-Blockers Show No Added Benefit After MI With Preserved LVEF
5





























































